Loading
Latest filing published 02 Jun 2008 for SCOLR Pharma, Inc., €2,477.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Richard M. Levy discloses dealings in SCOLR Pharma, Inc. to SEC (Form 4). In total, 13 filings cover trades dated from 16 March 2007 to 30 May 2008.
Every open-market trade on record is a purchase: 12 purchases worth €35k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant. 2008 to date brings 2 purchases and no sales.
Half of the purchases are above €1,675 and half below.
The latest filing, published on 2 June 2008, reports an open-market purchase of €1,052 in SCOLR Pharma, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations